Nippon Life Insurance Company Lowered Pfizer (PFE) Holding; Isramco (ISRL) Sentiment Is 1.63

February 25, 2018 - By Migdalia James

Nippon Life Insurance Company decreased Pfizer Inc (PFE) stake by 1.53% reported in 2017Q3 SEC filing. Nippon Life Insurance Company sold 18,907 shares as Pfizer Inc (PFE)’s stock declined 3.45%. The Nippon Life Insurance Company holds 1.22M shares with $43.42M value, down from 1.24 million last quarter. Pfizer Inc now has $216.14B valuation. The stock increased 1.45% or $0.52 during the last trading session, reaching $36.26. About 17.02 million shares traded. Pfizer Inc. (NYSE:PFE) has declined 2.76% since February 25, 2017 and is downtrending. It has underperformed by 19.46% the S&P500.

Isramco, Inc., an independent oil and natural gas company, engages in the exploration, development, and production of oil and natural gas properties located onshore in the United States and offshore Israel. The company has market cap of $282.64 million. It operates through two divisions, Oil and Gas Exploration and Production; and Production Services. It has a 24.14 P/E ratio. The Oil and Gas Exploration and Production segment owns working interests in gas and oil wells in Louisiana, Texas, New Mexico, Oklahoma, Wyoming, Utah, and Colorado; and operates approximately 515 producing wells located primarily in Texas and New Mexico.

American International Group Inc holds 0% of its portfolio in Isramco, Inc. for 491 shares. Ameritas Investment Partners Inc. owns 85 shares or 0% of their US portfolio. Moreover, Bank Of America Corp De has 0% invested in the company for 285 shares. The New York-based Bank Of New York Mellon Corp has invested 0% in the stock. Barclays Plc, a United Kingdom-based fund reported 14 shares.

It closed at $104 lastly. It is down 40.51% since February 25, 2017 and is uptrending. It has outperformed by 23.81% the S&P500.

Nippon Life Insurance Company increased Regeneron Pharmaceuticals (NASDAQ:REGN) stake by 1,492 shares to 6,522 valued at $2.92M in 2017Q3. It also upped Devon Energy Corp New (NYSE:DVN) stake by 9,145 shares and now owns 34,801 shares. Anadarko Pete Corp (NYSE:APC) was raised too.

Since August 31, 2017, it had 0 buys, and 7 sales for $12.30 million activity. READ IAN C had sold 197,168 shares worth $6.70M. $249,750 worth of Pfizer Inc. (NYSE:PFE) was sold by MACKENZIE ALEXANDER R on Friday, December 15. SUSMAN SALLY sold $1.34 million worth of stock. The insider DAMELIO FRANK A sold $3.21 million. 8,000 Pfizer Inc. (NYSE:PFE) shares with value of $296,560 were sold by JOHNSON RADY A.

Investors sentiment increased to 0.96 in Q3 2017. Its up 0.02, from 0.94 in 2017Q2. It increased, as 53 investors sold PFE shares while 700 reduced holdings. 106 funds opened positions while 620 raised stakes. 4.06 billion shares or 0.86% more from 4.02 billion shares in 2017Q2 were reported. Cambridge Incorporated owns 14,905 shares. The California-based Mraz Amerine has invested 0.14% in Pfizer Inc. (NYSE:PFE). Regent Management Ltd Liability holds 64,915 shares or 0.78% of its portfolio. Altavista Wealth Management Inc holds 45,116 shares or 0.77% of its portfolio. 95,943 are owned by Valueworks Limited Liability Corp. Brandywine Glob Investment Management Llc holds 6.70M shares or 1.52% of its portfolio. Goldman Sachs Gru Inc Inc accumulated 49.53 million shares or 0.43% of the stock. Legacy Private Communications reported 0.26% of its portfolio in Pfizer Inc. (NYSE:PFE). Essex Management Ltd Liability Co accumulated 19,213 shares. Stuyvesant Cap holds 10.13% of its portfolio in Pfizer Inc. (NYSE:PFE) for 139,515 shares. 27,772 were reported by Halsey Assoc Ct. Nuveen Asset Mngmt Limited Liability Corporation stated it has 1.70 million shares or 0.4% of all its holdings. Tnb Finance reported 93,578 shares. Lee Danner & Bass invested in 0.66% or 171,972 shares. Greylin Inv Mangement Inc holds 56,948 shares or 0.47% of its portfolio.

Among 22 analysts covering Pfizer (NYSE:PFE), 10 have Buy rating, 1 Sell and 11 Hold. Therefore 45% are positive. Pfizer had 74 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Monday, June 12 by BMO Capital Markets. The rating was maintained by Piper Jaffray on Friday, August 14 with “Buy”. The rating was upgraded by Cowen & Co on Tuesday, October 20 to “Outperform”. The rating was initiated by Berenberg with “Hold” on Thursday, May 12. The firm has “Buy” rating by Cowen & Co given on Monday, September 18. UBS maintained Pfizer Inc. (NYSE:PFE) rating on Wednesday, November 1. UBS has “Buy” rating and $38.0 target. Barclays Capital upgraded the shares of PFE in report on Tuesday, November 29 to “Overweight” rating. The stock of Pfizer Inc. (NYSE:PFE) earned “Neutral” rating by Morgan Stanley on Friday, April 7. The firm earned “Hold” rating on Tuesday, August 1 by BMO Capital Markets. BMO Capital Markets maintained the stock with “Buy” rating in Tuesday, November 21 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Migdalia James

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts